International Medical Vice President, Obesity&NASH, Clinical Drug Development @novonordisk. Honorary Professor @UoB_MSS . Own views Obesity,Diabetes,Sleep,Neuro
Sep 13, 2024 • 7 tweets • 5 min read
The glucose derived personalised HbA1c correction study session was one of the best in #EASD2024 . Chaired by @scelee1 with great talks from @AjjanRamzi @drpratikc and Tim Dunn. Slides shared with permission of the authors. Not all data published. #diabetes ⬇️
Wide variation in HbA1c with average glucose levels. The resulting positive and negative glycation gap is associated with increased mortality. This gap is related to red cell characteristics and ethnicity #EASD2024 #diabetes ⬇️
Apr 12, 2021 • 12 tweets • 11 min read
Thread: So please see below. I happened today to read the #obesity page on the @NHSEngland website. The content and statements really surprised me. There are many positive aspects such as highlighting BMI limitations and the use of waist circumference&⬇️
nhs.uk/conditions/obe…
mentioning the multiple treatment options and the need for psychology, talking about #obesity complications and that modest weight lost has health benefits amongst other positive features. But there are several features that really need improvement ⬇️
gov.uk/government/new…
This is a very welcome step from the government and any policy that reduce the burden of #obesity obesity is very welcome. But this step fall short of a whole system approach that addressed the multiple factors contributing to obesity simultaneously